Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022)

Agios Pharmaceuticals' Capital Leases history spans 4 years, with the latest figure at $276000.0 for Q1 2022.

  • For Q1 2022, Capital Leases rose 11.29% year-over-year to $276000.0; the TTM value through Mar 2022 reached $276000.0, up 11.29%, while the annual FY2021 figure was $276000.0, 16.62% down from the prior year.
  • Capital Leases reached $276000.0 in Q1 2022 per AGIO's latest filing, roughly flat from $276000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $673000.0 in Q4 2019 to a low of $167000.0 in Q2 2021.
  • Average Capital Leases over 4 years is $340428.6, with a median of $276000.0 recorded in 2021.
  • Peak YoY movement for Capital Leases: plummeted 50.82% in 2020, then increased 11.29% in 2022.
  • A 4-year view of Capital Leases shows it stood at $673000.0 in 2019, then tumbled by 50.82% to $331000.0 in 2020, then dropped by 16.62% to $276000.0 in 2021, then changed by 0.0% to $276000.0 in 2022.
  • Per Business Quant, the three most recent readings for AGIO's Capital Leases are $276000.0 (Q1 2022), $276000.0 (Q4 2021), and $167000.0 (Q2 2021).